Zim Laboratories Limited has informed the Exchange about Acquisition

Strategic Transactions View source PDF Explain this filing

ZIMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹115.37

prior close

₹114.02

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+0.2% vs market

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.3

15m

+0.4

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-0.3-0.5+0.2

Next day

-1.6-0.4-1.3

+0.1+0.9-0.8

-2.5+1.3-3.8

+6.5+1.6+4.9

+3.1+1.1+2.1

+1.1+0.9+0.2

15d

-7.2-3.3-3.9

-34.5-5.1-29.5

-34.9-2.3-32.6

-38.5-3.9-34.6

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zim Laboratories' wholly owned subsidiary ZIM FZE has completed an investment of AED 4,00,000 in the share capital of ZIM Scientific Office LLC (ZIM SO), a step-down subsidiary based in the UAE. This is part of previously disclosed plans to infuse AED 1,00,000 and AED 4,66,000 as informed to the exchange in August 2024 and March 2025. After this investment, ZIM FZE continues to hold 100% of ZIM SO, meaning the ownership structure remains unchanged. The investment was made through internal corporate restructuring rather than acquiring any new entity.

Likely market impact

No material impact for shareholders — this is a routine internal capital infusion into a wholly owned step-down subsidiary, and the parent's ownership stake remains 100%, so there is no dilution or change in control.